Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(17)
DRUG(1)
laboratory biomarker analysis
5 trials
not_applicablephase_1
wake-forest-university-health-sciences
medical chart review
2 trials
wake-forest-university-health-sciences
trivalent influenza vaccine
2 trials
phase_1
wake-forest-university-health-sciences
questionnaire administration
2 trials
not_applicable
wake-forest-university-health-sciences
quality-of-life assessment
2 trials
not_applicable
wake-forest-university-health-sciences
erlotinib hydrochloride
1 trial
phase_1
wake-forest-university-health-sciences
protein expression analysis
1 trial
phase_1
wake-forest-university-health-sciences
bovine lactoferrin
1 trial
not_applicable
wake-forest-university-health-sciences

+2 more interventions

10 unique interventions2 categories

Analytics

Trial Phases

Phase 12

Trial Status

Completed5
Terminated2

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT01596634Not ApplicableCompleted
Bovine Lactoferrin in Reducing Taste Disturbances in Patients With Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy
Colorectal CancerDysgeusiaOral Complications of Chemotherapy
PrincipalinvestigatorStart date: 2013-01-01
NCT01474174Completed
Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors
Central Nervous System Neoplasm
PrincipalinvestigatorStart date: 2011-09-01
NCT02208336Completed
Electronic Medical Record Review in Monitoring the Effects of Adherence on Myelosuppression and Morbidity in Patients With Newly Diagnosed Brain Tumors Receiving Temozolomide and Radiation Therapy
Brain Tumor
PrincipalinvestigatorStart date: 2010-10-01
NCT01103375Phase 1Terminated
Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+6 more
Principalinvestigator
NCT01941758Phase 1Completed
High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors
Central Nervous System Neoplasm
Principalinvestigator
NCT01941810Not ApplicableCompleted
Bovine Lactoferrin Supplement in Improving Taste in Patients With Cancer Receiving Chemotherapy
AnorexiaCachexiaMalignant Neoplasm+1 more
Principalinvestigator
NCT02375334Terminated
Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation Therapy
Malignant GliomaMyelosuppression
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

AnorexiaCachexiaCancer+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Brain NeoplasmsCancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

CancerColorectal Cancer
Similarity Score3%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Colorectal CancerMalignant Glioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Colorectal CancerBrain Neoplasms
Similarity Score3%

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

Related
13 trials

Shared therapeutic areas:

Brain NeoplasmsColorectal Cancer
Similarity Score3%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Cancer
Similarity Score2%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Cancer
Similarity Score2%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Brain Neoplasms
Similarity Score2%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Colorectal Cancer
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT01596634Not ApplicablePrincipalInvestigator

Bovine Lactoferrin in Reducing Taste Disturbances in Patients With Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy

Colorectal CancerDysgeusiaOral Complications of Chemotherapy
Completed
NCT01474174PrincipalInvestigator

Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors

Central Nervous System Neoplasm
Completed
NCT02208336PrincipalInvestigator

Electronic Medical Record Review in Monitoring the Effects of Adherence on Myelosuppression and Morbidity in Patients With Newly Diagnosed Brain Tumors Receiving Temozolomide and Radiation Therapy

Brain Tumor
Completed
NCT01103375Phase 1PrincipalInvestigator

Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma

Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+6 more
Terminated
NCT01941758Phase 1PrincipalInvestigator

High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors

Central Nervous System Neoplasm
Completed
NCT01941810Not ApplicablePrincipalInvestigator

Bovine Lactoferrin Supplement in Improving Taste in Patients With Cancer Receiving Chemotherapy

AnorexiaCachexiaMalignant Neoplasm+1 more
Completed
NCT02375334PrincipalInvestigator

Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation Therapy

Malignant GliomaMyelosuppression
Terminated

All 7 trials loaded